|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61B 5/145 | |
| A61B 5/00 | |||
| A61K 38/12 | |||
| G01N 33/68 | |||
| A61K 38/10 | |||
| A61K 39/395 |
| (11) | Number of the document | 2723361 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12803380.0 |
| Date of filing the European patent application | 2012-06-22 | |
| (97) | Date of publication of the European application | 2014-04-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/043845 |
| Date | 2012-06-22 |
| (87) | Number | WO 2012/178083 |
| Date | 2012-12-27 |
| (30) | Number | Date | Country code |
| 201161499895 P | 2011-06-22 | US |
| (72) |
FRANCOIS, Cedric, US
DESCHATELETS, Pascal, US
|
| (73) |
Apellis Pharmaceuticals, Inc.,
6400 Westwind Way Suite A, Crestwood, KY 40014,
US
|
| (54) | METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS |
| METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS |